Skip to main content

What the FDA labels say about taking them together

Digoxin and istradefylline

Istradefylline's FDA label of May 20, 2025 names digoxin in its drug interactions section; the digoxin labels PlainMeds reads (3) do not name istradefylline. The istradefylline label: “P-glycoprotein (P-gp) Substrates Coadministration of NOURIANZ with a P-gp substrate (digoxin) increased the P-gp substrate C max and AUC inf by 33% and 21%, respectively.”

Check it at the source: the digoxin FDA label on DailyMed (effective December 5, 2024, Advanz Pharma (US) Corp.); the istradefylline FDA label on DailyMed (effective May 20, 2025, Kyowa Kirin, Inc.).

What does the digoxin label say about istradefylline?

Digoxin's label (effective December 5, 2024) and its 2 other brand-application labels do not name istradefylline in these sections. A label lists what its studies and reports found; it is not a complete list.

Source: FDA drug label (LANOXIN), Advanz Pharma (US) Corp., effective December 5, 2024 (SPL set d91e3646-4c63-4512-ab22-db39c085c4dc), via openFDA; the full label on DailyMed

What does the istradefylline label say about digoxin?

Istradefylline label, drug interactions

P-glycoprotein (P-gp) Substrates Coadministration of NOURIANZ with a P-gp substrate (digoxin) increased the P-gp substrate C max and AUC inf by 33% and 21%, respectively [see Clinical Pharmacology (12.3) ].

Source: FDA drug label (NOURIANZ), Kyowa Kirin, Inc., effective May 20, 2025 (SPL set a7d008cb-b273-4049-a5d2-9c6902910d58), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

26Digoxin generic labelers
0Istradefylline generic labelers
DigoxinIstradefylline
Labeled forHeart failure, Atrial fibrillationParkinson's disease
Boxed warningNoNo
Pharmacy cost (NADAC)$0.133 per tablet 125 mcg tabletn/a
Shortage nowNo current entryNo current entry

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?